glutathione neuroprotection in HIV-Associated Neurocognitive Disorders Schematic representation of neuroprotective mechanisms

10.1038/srep17070 84 SievertD

Category 2 of the FDA's 503A list is reserved for bulk drug substances that "raise significant safety concerns." Placement in this category essentially prohibits compounding pharmacies from using the substance to prepare formulations for patients

Carbon Lett 32:365393

Patient Selection for Combination Therapy Choosing who gets combination therapy with Tiaminal B12 is detailed

The naturally occurring peptide GHK-Cu (GHK from glycyl-L-histidyl-L-lysine bound to a copper ion), which affects 31.2% of the human genes by either activating or deactivating them (based on a criterion of a reduction or increment in gene activity of more than 50%), meaning that it works by inducing epigenetic alterations in the cells

Existing data suggests that there is a direct relationship between anaphylactoid reactions and serum NAC concentration [31]